CONTEXT: Ghrelin is known to play a role in glucose metabolism and in beta-cell function. There are controversies regarding the role of ghrelin polymorphisms in diabetes and diabetes-related phenotypes. OBJECTIVE: The objective of this study was to examine polymorphisms of the ghrelin gene in a Korean cohort and investigate associations between them and susceptibility to type 2 diabetes and its related phenotypes. DESIGN AND PATIENTS: The ghrelin gene was sequenced to identify polymorphisms in 24 DNA samples. Common variants were then genotyped in 760 type 2 diabetic patients and 641 nondiabetic subjects. Genetic associations with diabetes-related phenotypes were also analyzed. RESULTS: Nine polymorphisms were identified, and four common polymorphisms [g.-1500C>G, g.-1062G > C, g.-994C > T, g.+408C > A (Leu72Met)] were genotyped in a larger study. The genotype distributions of these four common polymorphisms in type 2 diabetes patients were similar to those of normal nondiabetic controls. However, these four common polymorphisms were variably associated with several diabetes-related phenotypes, such as high-density lipoprotein (HDL) cholesterol, fasting plasma glucose, and homeostasis model assessment of insulin resistance. In particular, subjects harboring g.-1062C were associated with a lower serum HDL cholesterol level after adjusting for other variables (P = 0.0004 or 0.01 after Bonferroni correction for 24 tests). CONCLUSION: The aforementioned four common polymorphisms in the ghrelin gene were not found to be significantly associated with susceptibility to type 2 diabetes mellitus in the Korean population. However, the common polymorphism g.-1062G > C in the promoter region of the ghrelin gene was found to be significantly associated with serum HDL cholesterol levels.
CONTEXT: Ghrelin is known to play a role in glucose metabolism and in beta-cell function. There are controversies regarding the role of ghrelin polymorphisms in diabetes and diabetes-related phenotypes. OBJECTIVE: The objective of this study was to examine polymorphisms of the ghrelin gene in a Korean cohort and investigate associations between them and susceptibility to type 2 diabetes and its related phenotypes. DESIGN AND PATIENTS: The ghrelin gene was sequenced to identify polymorphisms in 24 DNA samples. Common variants were then genotyped in 760 type 2 diabeticpatients and 641 nondiabetic subjects. Genetic associations with diabetes-related phenotypes were also analyzed. RESULTS: Nine polymorphisms were identified, and four common polymorphisms [g.-1500C>G, g.-1062G > C, g.-994C > T, g.+408C > A (Leu72Met)] were genotyped in a larger study. The genotype distributions of these four common polymorphisms in type 2 diabetespatients were similar to those of normal nondiabetic controls. However, these four common polymorphisms were variably associated with several diabetes-related phenotypes, such as high-density lipoprotein (HDL) cholesterol, fasting plasma glucose, and homeostasis model assessment of insulin resistance. In particular, subjects harboring g.-1062C were associated with a lower serum HDL cholesterol level after adjusting for other variables (P = 0.0004 or 0.01 after Bonferroni correction for 24 tests). CONCLUSION: The aforementioned four common polymorphisms in the ghrelin gene were not found to be significantly associated with susceptibility to type 2 diabetes mellitus in the Korean population. However, the common polymorphism g.-1062G > C in the promoter region of the ghrelin gene was found to be significantly associated with serum HDL cholesterol levels.
Authors: D Benaiges; J A Flores-Le-Roux; J Pedro-Botet; J M Ramon; A Parri; M Villatoro; M J Carrera; M Pera; E Sagarra; L Grande; A Goday Journal: Obes Surg Date: 2012-08 Impact factor: 4.129
Authors: Juan-Patricio Nogueira; Marie Maraninchi; Sophie Béliard; Anne Marie Lorec; Bruno Berthet; Audrey Bégu-Le Corroller; Noémie Dubois; Rachel Grangeot; Catherine Mattei; Jean Gaudart; Alain Nicolay; Henri Portugal; Bernard Vialettes; René Valéro Journal: Nutr Metab (Lond) Date: 2012-03-13 Impact factor: 4.169
Authors: Mireia Mora; Victoria Adam; Elisabet Palomera; Sebastian Blesa; Gonzalo Díaz; Xavier Buquet; Mateu Serra-Prat; Juan Carlos Martín-Escudero; Ana Palanca; Javier Felipe Chaves; Manuel Puig-Domingo Journal: PLoS One Date: 2015-09-16 Impact factor: 3.240
Authors: Faris Elbahi Joatar; Ali Ahmed Al Qarni; Muhalab E Ali; Abdulaziz Al Masaud; Abdirashid M Shire; Nagalla Das; Khalid Gumaa; Hayder A Giha Journal: Endocrinol Metab (Seoul) Date: 2017-09